Free Trial
NASDAQ:ASPI

ASP Isotopes Q1 2024 Earnings Report

ASP Isotopes logo
$9.10 +0.94 (+11.44%)
As of 11:23 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ASP Isotopes EPS Results

Actual EPS
-$0.16
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ASP Isotopes Revenue Results

Actual Revenue
$0.84 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

ASP Isotopes Announcement Details

Quarter
Q1 2024
Time
N/A
Conference Call Date
Wednesday, May 15, 2024
Conference Call Time
7:00AM ET

Upcoming Earnings

ASP Isotopes' Q2 2025 earnings is scheduled for Monday, August 18, 2025, with a conference call scheduled on Thursday, August 14, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

ASP Isotopes Earnings Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
See More ASP Isotopes Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ASP Isotopes? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ASP Isotopes and other key companies, straight to your email.

About ASP Isotopes

ASP Isotopes (NASDAQ:ASPI), Inc. (NASDAQ: ASPI) is a specialty materials company focused on the production, purification and distribution of both stable and radioactive isotopes. The company’s core offerings include high-purity isotopic materials for use in nuclear medicine, radiopharmaceutical development, advanced research and industrial applications. With proprietary separation and purification technologies, ASP Isotopes delivers customizable solutions that meet stringent regulatory and quality standards demanded by biotechnology firms, hospitals and government research facilities.

Founded in 2021 and headquartered in Germantown, Maryland, ASP Isotopes operates an integrated manufacturing network that spans isotope extraction, chemical conversion and final packaging. The company’s vertically integrated model allows for enhanced traceability and process control at every stage of production, from raw material procurement through refined isotope delivery. This integration not only streamlines lead times but also supports the development of niche isotopic species and tailored formulations that are critical to emerging therapies and diagnostic imaging protocols.

ASP Isotopes’ global footprint includes distribution centers and partnerships across North America, Europe and Asia, ensuring reliable supply chains for customers worldwide. The firm collaborates with premier academic institutions and national laboratories to advance isotope research and accelerate the transfer of novel radiopharmaceuticals to clinical trials. In parallel, ASP Isotopes engages in strategic alliances with industrial OEMs to supply isotopes used in electronics manufacturing, environmental monitoring and non‐destructive testing applications.

Under the leadership of President and CEO Dr. Emily Richards, a seasoned executive with over two decades of experience in radiochemical manufacturing and regulatory affairs, ASP Isotopes has prioritized quality assurance and regulatory compliance. The company’s management team combines expertise in chemical engineering, nuclear physics and pharmaceutical development, positioning ASP Isotopes to capitalize on growing demand for specialized isotopes. As the medical and industrial sectors continue to expand their reliance on isotopic technologies, ASP Isotopes aims to reinforce its role as a trusted supplier while pursuing incremental capacity expansions and advancements in separation techniques.

View ASP Isotopes Profile

More Earnings Resources from MarketBeat